Beryl Drugs News

Beryl Drugs approves FY26 audited results

Beryl Drugs Limited board approved audited financial statements for FY26 on May 28, 2026. The meeting also took on record the statutory auditor's report.

Beryl Drugs Board Meeting on May 28

Beryl Drugs Limited has scheduled a board meeting for May 28, 2026, to consider audited financial results for FY26.

Beryl Drugs EGM Approves Rs. 5 Cr RPT and Director Appointments

Beryl Drugs' EGM on May 11, 2026 approved three resolutions: regularisation of Mr. Shailendra Pathak as WTD, appointment of Mrs. Neha Sarda as Independent Director, and a Rs. 5 Cr RPT with Aminova Infusions.

Beryl Drugs EGM Approves Rs. 5 Cr RPT with Aminova Infusions

Beryl Drugs' EGM on May 11, 2026 approved a Rs. 5 Cr material related party transaction with Aminova Infusions Pvt. Ltd. for product distribution in Maharashtra, Gujarat, and export markets.

Beryl Drugs EGM Regularises Pathak & Sarda as Directors

Beryl Drugs EGM on May 11, 2026 regularised Shailendra Pathak as Whole-Time Director for 5 years and Neha Sarda as Independent Director for 5 years from May 11, 2026.